Pharvaris HAE drug shows faster symptom relief in Lancet study

PepsiCo Maintains Food and Beverage Volume Growth. Here’s Why Earnings Are Under Pressure Anyway.

NASDAQ · Markets 26m ago

Australian Nvidia-backed AI data centre operator Firmus scraps $5 billion IPO

Investing.com · News 30m ago

Star Equity CEO Jeffrey Eberwein sells $27,540 in preferred stock

Investing.com · News 33m ago

Neuraxis CEO Brian Carrico buys $1,297 in company stock

Investing.com · News 33m ago

Neuraxis CRO Carrico buys $1,587 in common stock

Investing.com · News 34m ago

Neuraxis CFO Timothy Henrichs buys $9,375 in company stock

Investing.com · News 34m ago

Barclays’ Lauren Lieberman on PepsiCo Earnings

Bloomberg · Markets Video 36m ago

Exclusive-Southwest Airlines weighs Boeing 787 for long-haul international push, sources say

Investing.com · News 37m ago

Earnings call transcript: Park Aerospace tops Q2 2026 estimates, shares rise

Investing.com · News 40m ago

Getty Copper closes C$15M flow-through share financing

Investing.com · News 41m ago